Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs

Cost-effectiveness of vaccination against pneumococcal infection of adults at risk within the federal and regional programs

The aim. of the work was to evaluate the cost-effectiveness of vaccination with the 13-vaIent pneumococcal conjugate vaccine (PCV13) and its combination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) of immunocompetent adult patients with different levels of risk of pneumococcal infe...

Full description

Bibliographic Details
Main Authors: A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, L. S. Namazova-Baranova, O. M. Drapkina, S. N. Avdeev, L. Yu. Drozdova, G. L. Ignatova, I. S. Koroleva, V. A. Korshunov, M. P. Kostinov
Format: Article
Language:Russian
Published: Journal Infectology 2019-12-01
Series:Žurnal Infektologii
Subjects:
pneumonia
vaccinal prevention
adults
pneumococcal conjugated vaccine
cost-effectiveness
Online Access:https://journal.niidi.ru/jofin/article/view/956

Internet

https://journal.niidi.ru/jofin/article/view/956

Similar Items